US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
↗
Today 9:05 EDT
Via
The Motley Fool
Topics
ETFs
Tickers
IVZ
MRNA
QQQ
Exposures
COVID-19
Product Safety
IntelliXR Launches Its Platform for Eye and Brain Biomarkers
October 17, 2026
Via
Press Release Distribution Service
Exposures
Product Safety
The Nasdaq-100's 6 Best Stocks This Year, and Whether They Can Keep Going
↗
October 17, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Tickers
AMD
INTC
MRNA
MRVL
MU
NVDA
Exposures
Artificial Intelligence
Product Safety
Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to a Securities Fraud Lawsuit - Lead Plaintiff Deadline is November 3, 2026
October 16, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
DataMeds Applauds FDA’s Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health’s Peptides Roadmap
October 16, 2026
Via
B2i Digital
Topics
Artificial Intelligence
Tickers
MEDS
Exposures
Artificial Intelligence
Product Safety
Adagene Highlights SAFEbody Pipeline, ADG138 Clinical Launch and 2027 Catalysts
↗
October 16, 2026
Via
MarketBeat
Tickers
ADAG
Exposures
Product Safety
Guy Gentile Announces The Short Seller, a New Book on the Mechanics and Risks of Short Selling
October 16, 2026
Via
Newsfile
Topics
Product Recall
Regulatory Compliance
Tickers
AMZN
VLKAF
VWAGY
VWAPY
Exposures
Legal
Product Safety
Regulatory
Kaplan Fox Alerts Investors to an Upcoming Deadline of November 2, 2026 in the Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Securities Class Action
October 16, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
UNCY
Exposures
Financial
Legal
Product Safety
The Road to Diagnosis: Cindy’s Journey With Non-Cystic Fibrosis Bronchiectasis
October 16, 2026
Via
StatePoint Media
Topics
Product Recall
Exposures
Legal
Product Safety
Kaplan Fox Advises Investors of Beta Bionics, Inc. (NASDAQ: BBNX) of an Upcoming Securities Class Action Deadline on November 3, 2026
October 15, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
October 15, 2026
Via
PRLog
Exposures
Product Safety
FAIR Act aims to improve rare disease clinical trial, treatment access
October 15, 2026
Via
Brandpoint
Exposures
Product Safety
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Joins European Cardiovascular Research Consortium to Lead HEART-CHECK Study
October 15, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
BEAT
Exposures
Intellectual Property
Product Safety
Kaplan Fox Reminds Investors of the November 3, 2026 Deadline in the Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX)
October 15, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
Smoke App Expands Online Ordering and Local Delivery for Smoke Shops, Vape and Cigar Retailers
October 14, 2026
Via
Newsfile
Exposures
Product Safety
Kaplan Fox Announces the Lead Plaintiff Deadline of November 3, 2026 in the Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX)
October 14, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Gains FDA Clearance to Test Distinct Approach to MS Treatment
October 14, 2026
Via
Investor Brand Network
Tickers
QNTM
Exposures
Product Safety
Non-Invasive Auricular Vagus Nerve Stimulator: New Science-Based Guide Released
October 14, 2026
Via
Press Release Distribution Service
Exposures
Product Safety
Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
↗
October 14, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
QNTM
TMO
Exposures
Artificial Intelligence
Product Safety
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Seek Leadership in a Securities Fraud Lawsuit by November 2, 2026
October 14, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
UNCY
Exposures
Financial
Legal
Product Safety
Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to an Approaching Lead Plaintiff Deadline on November 3, 2026
October 13, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
Light Adjustable Lens in Siouxland: Customizable Cataract Surgery
October 13, 2026
Via
Press Advantage
Exposures
Product Safety
Nadosei Releases 2026 NMN Buyer's Guide That Compares 13 Brands
October 13, 2026
Via
Press Advantage
Exposures
Product Safety
TechMediaBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Submits FDA Response for SSi Mantra Surgical Robotic System
October 13, 2026
Via
Investor Brand Network
Tickers
ARM
SSII
Exposures
Product Safety
Eli Lilly Reports Earnings on Oct. 29. Here's Why the Retatrutide Story Matters More Than the Quarter.
↗
October 13, 2026
Via
The Motley Fool
Tickers
LLY
Exposures
Product Safety
Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm Before the Securities Class Action Deadline on November 3, 2026
October 13, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
↗
October 13, 2026
Via
The Motley Fool
Tickers
MRNA
VRTX
Exposures
COVID-19
Product Safety
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Seek a Leadership Role Before Deadline on November 3, 2026
October 12, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
BBNX
Exposures
Financial
Legal
Product Safety
Where Will Axsome Therapeutics Be in 2030 as Auvelity Expands Into Alzheimer's?
↗
October 12, 2026
Via
The Motley Fool
Tickers
AXSM
Exposures
Product Safety
Biogen (BIIB) Stock Is Up, What You Need To Know
October 12, 2026
Via
StockStory
Topics
Earnings
Tickers
BIIB
JPM
LLY
Exposures
Financial
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >